Druck Icon
 

Eckert & Ziegler Isotope Products announces new 5 year distribution agreement with Cardinal Health

Valencia, California, USA, August 7, 2008 - Eckert & Ziegler Isotope Products (EZIP) has successfully extended, for another five years, its existing distribution agreement with Cardinal Health Inc., one of the largest operators of Nuclear Pharmacies in North America. Cardinal Health will market the full line of EZIP Medical imaging products in the U.S, including calibration and reference sources for imaging applications, such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and multi modality applications. The Dublin, Ohio based company will also market EZIP's flexible Cobalt-57 flood source, Perflexion.

Known for its broad portfolio of products, EZIP has become the world's leading supplier of Nuclear Medicine calibration standards. Recent innovations such as the new Soft Sided storage case for the WolfGuardTM shield have put EZIP at the forefront of Nuclear Medicine source and shielding development. EZIP sells its products via various avenues, including direct to users, international distributors in over 30 countries and in partnerships with original equipment manufacturers.

About Eckert & Ziegler Isotope Products: For over forty (40) years, Eckert & Ziegler Isotope Products, (a subsidiary of Eckert & Ziegler AG) has been producing instrumentation and calibration standards. Today it is the world's leading manufacturer for nuclear imaging reference and calibration standards and a leading producer of radioactive components for industrial, scientific and medical applications.

Eckert & Ziegler AG is a global isotope technology company that processes radioisotopes as well as develops, manufactures and sells isotope technology components, medical technology equipment and related products. The group employs about 430 people worldwide. Throughout all of its subsidiaries it generates yearly consolidated revenues in excess of $ 100 MM (70 Mio. EUR). Eckert & Ziegler AG is listed in the Prime Standard of the German Stock Exchange in Frankfurt am Main (ISIN DE0005659700).

The Board of Directors